- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trastuzumab emtansine [Kadcyla]
Total 1172 results
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityWithdrawnLocal Recurrence of Malignant Tumor of Breast
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Youzhi ZhuRecruitingBreast Cancer FemaleChina
-
National Cancer Institute (NCI)CompletedCancerUnited States
-
Spanish Breast Cancer Research GroupAstraZenecaRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerSpain
-
M.D. Anderson Cancer CenterDaiichi SankyoRecruiting
-
Cynthia Owusu, MDNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedMalignant Neoplasm | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Adenocarcinoma of the Gallbladder | Adenocarcinoma of the Extrahepatic Bile DuctUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Daiichi SankyoAstraZenecaCompletedAdenocarcinoma Gastric Stage IV With Metastases | Adenocarcinoma - GEJUnited States, Spain, Belgium, Italy, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast CancerUnited States
-
Jules Bordet InstituteCompletedBreast Neoplasms | Secondary | HER2 Positive Carcinoma of BreastBelgium
-
AstraZenecaNot yet recruiting
-
Silverback TherapeuticsTerminatedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Colorectal Cancer | HER2-expressing Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | HER2-Positive Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
University of WashingtonUnited States Department of DefenseRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingGlioblastoma | Brain Cancer | Metastatic Cancer | Recurrent Glioblastoma | Leptomeningeal MetastasisUnited States
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
Washington University School of MedicineNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedRecurrent Salivary Gland Cancer | Stage IVA Salivary Gland Cancer | Stage IVB Salivary Gland Cancer | Stage IVC Salivary Gland Cancer | High-grade Salivary Gland Mucoepidermoid Carcinoma | Salivary Gland Acinic Cell Tumor | Salivary Gland Adenocarcinoma | Salivary Gland Poorly Differentiated CarcinomaUnited States
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
European Organisation for Research and Treatment...GlaxoSmithKlineCompletedBreast CancerFrance, United Kingdom, Belgium, Switzerland, Slovenia
-
National Cancer Institute (NCI)SuspendedOsteosarcoma | Recurrent OsteosarcomaUnited States
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
MedSIRDaiichi Sankyo, Inc.CompletedAdvanced Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | Leptomeningeal MetastasisSpain, Portugal
-
Fudan UniversityNot yet recruiting
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
University of SouthamptonAstraZeneca; Natera, Inc.RecruitingGastrooesophageal CancerUnited Kingdom
-
Hoffmann-La RocheTerminated
-
Tohoku UniversityCompleted
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingAdvanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)China
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHER2-positive Advanced Gastric Cancer | HER2-positive Gastroesophageal Junction AdenocarcinomaAustria, Belgium, Germany, Italy
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
AstraZenecaDaiichi SankyoActive, not recruitingHER2-mutant Non-Small Cell Lung CancerChina
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
PfizerCompletedMetastatic Breast CancerKorea, Republic of, Serbia, Argentina, Brazil, Japan, Peru, Turkey, United States, Slovakia, Mexico, Philippines, Poland, Romania, Hungary, India, Portugal, South Africa, Latvia, Thailand, Russian Federation, Ukraine, Chile, Czechia, ...
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
Boehringer IngelheimTerminated
-
UNICANCERTerminated
-
Azienda Ospedaliera Ordine Mauriziano di TorinoUnknownMetastatic Breast CancerItaly
-
National Cancer Institute (NCI)NRG OncologyRecruitingEndometrial Serous Adenocarcinoma | Uterine Corpus CarcinosarcomaUnited States, Puerto Rico
-
National University Hospital, SingaporeNot yet recruitingOther Solid Tumors | HER2+ Advanced Breast Cancer
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.CompletedNon-Small Cell Lung CancerUnited States, Spain, Japan, Netherlands, France
-
West German Study GroupMerck Sharp & Dohme LLC; NanoString Technologies, Inc.Completed
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
Hoffmann-La RocheCompleted
-
Guangdong Provincial People's HospitalUnknown